NAS:SAVA (USA) Also Trade In: Germany

Cassava Sciences Inc $ 48.58 -2.3 (-4.52%)

Volume:
2,032,438
Avg Vol (1m):
9,378,547
Market Cap $:
1.90 Bil
Enterprise Value $:
1.87 Bil
PE Ratio:
0.00
PB Ratio:
50.60
Warning! GuruFocus has detected 1 Severe warning sign with SAVA. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

SAVA News and Headlines - Cassava Sciences Inc

GuruFocus Articles Total 6
  • 1

These companies are working on neuroprotective agents and anti-inflammatories

In a GuruFocus article published on Aug. 25, I pointed out that until now, the over 200 testing programs conducted by pharmaceutical companies searching for an effective Alzheimer's drug have flopped.

The majority of these schemes have focused on addressing the physical changes in patients' brains. While many firms are still pursuing the physical (amyloid/tau) theory, numerous others are taking different routes to solve the Alzheimer's puzzle.

Neuroprotection agents

According to an article in Medical News Today, neuroprotectors cannot reverse existing damage, but may protect against it and slow any degeneration of the central nervous system. Therefore, the drugs

90 Views    Barry Cohen    2020-08-27 16:34
Insiders invest in Vaalco Energy, Dasan Zhone Solutions and Cassava Sciences

According to GuruFocus insider data, recent chief financial officer buys were Vaalco Energy Inc. (EGY), Dasan Zhone Solutions Inc. (DZSI) and Cassava Sciences Inc. (SAVA).

Vaalco Energy CFO bought 8,600 shares

CFO Elizabeth D. Prochnow bought 8,600 shares for $1.7 per share on May 14. Since then, the stock has declined 4.12%.

Vaalco Energy has a market cap of $97.460 million and its shares were traded around $1.63. The company has a price-earnings ratio of 1.05 and a price-sales ratio of 0.88.

The company announced its first-quarter results recently, posting revenue of $19.77 million and gross profit of $13.14 million,

26 Views    Myra Ramdenbourg    2019-05-23 19:35

Gevo, Inc. (GEVO) shares are up more than 21% in pre-market trading to $5.68 after the renewable chemicals and advanced biofuels company reported 1Q15 results. Gevo posted quarterly revenue of $5.9 million, a significant increase from $0.9 million in the same quarter of last year. The report also highlighted a recent renewable jet fuel agreement with Alaska Airlines.

Williams Partners LP (WPZ) is up nearly 15% to $54.40 per share following an announcement that all public equity of the natural gas company will be bought by Williams Companies Inc. Before the buyout, Williams owned 60% of WPZ. Furthermore, WPZ will

612 Views    TipRanks    2015-05-13 19:51

First Eagle Investment Management on Aug. 31 reported adding to positions in two holdings: CUI Global Inc. (CUI) and Pain Therapeutics Inc. (PTIE).

The First Eagle Funds focus on long-term absolute return while protecting against market downturns. Each of the funds have gained year to date.

The larger increase was a 22.38% boost in the fund’s CUI Global holding, reflecting new shares 385,927, according to GuruFocus Real Time Picks. The transaction brings the total holding size to 12,110,485 shares, a 10.23% stake in the company. First Eagle started the position in the first quarter:

1410471276481.png

1479 Views    Holly LaFon    2014-09-11 22:18

Here are some of the latest Real-Time Picks from the gurus:

Chase Coleman added a new holding of 3,600,000 shares of Tuniu Corp (TOUR) at the average price of $10.07 on 05/09/2014, as reported in the latest 13G filings by Chase Coleman (Trades, Portfolio). Tuniu operates as an online leisure travel company in China and had its IPO on May 5, 2014. Coleman is the only guru holding the stock.

Market Cap: 93.16 million, P/E: N/A

Business Predictability: Not Rated, Financial Strength: Not Rated, Profitability & Growth: Not Rated

1400017518583.png

952 Views    Chris Mydlo    2014-05-14 14:58
Pain Therapeutics (PITE) is a branded pharmaceutical development concern. The company is essentially hitched to King Pharmaceuticals (KG), and even more specifically to the success or failure of a single drug - Remoxy, a form of Oxycontin designed to resist chemical and physical manipulation. Let's take a look at PTIE's business model. The company receives revenues in three categories: collaboration, program fees, and milestones. All of these payments are coming from King in a joint-venture development program for Remoxy, as well as two other earlier stage candidates who's indications are not yet known. Collaboration revenues are reimbursements from King for
942 Views    guruek    2009-07-24 17:21

Headlines Total 86
  • 1

2021-02-26 $ 48.58 (-4.52%)
8:47am
7:40am
2021-02-25 $ 50.88 (-4.11%)
6:54am
2021-02-24 $ 53.06 (1.32%)
6:52am
2021-02-23 $ 52.37 (-1.23%)
4:45pm
11:01am
10:26am
2021-02-22 $ 53.02 (-4.91%)
11:01am
2021-02-18 $ 51 (-0.43%)
10:30am
2021-02-17 $ 51.22 (-1.18%)
4:45pm
2021-02-13 $ 46.12 (-4.3%)
6:59pm
2021-02-10 $ 49.29 (-14.37%)
11:40am
7:00am
2021-02-09 $ 57.56 (-5.13%)
8:39am
6:27am
2021-02-08 $ 60.67 (35.42%)
10:59am
2021-02-04 $ 63.43 (-27.88%)
9:37am
6:42am
2021-02-03 $ 87.95 (58.64%)
5:40pm
9:25am
8:17am
2021-02-02 $ 55.44 (141.15%)
5:49pm
11:03am
11:02am
2021-01-26 $ 19.43 (23.92%)
2:46pm
2021-01-23
7:01am
2021-01-13 $ 11.45 (39.98%)
8:00am
2021-01-04 $ 7.09 (3.96%)
10:59am
2020-12-22 $ 7.57 (-3.32%)
6:31am
2020-12-02 $ 7.53 (-2.46%)
6:42pm
2020-11-27 $ 7.76 (0.78%)
11:00am
2020-11-19 $ 7.47 (-0.13%)
9:08am
2020-11-18 $ 7.48 (-5.91%)
9:36am
7:33am
2020-11-16 $ 8.13 (-2.87%)
9:06am
2020-11-13 $ 8.37 (-25.13%)
11:00am
8:42am
8:07am
7:01pm
2020-11-09 $ 10.16 (-5.05%)
11:01am
2020-11-04 $ 11.54 (25.57%)
11:00am
2020-11-03 $ 9.19 (2.91%)
7:26am
2020-10-26 $ 9.07 (-2.68%)
8:19am
2020-10-23 $ 9.32 (5.55%)
10:15am
2020-10-07 $ 12.13 (6.87%)
9:35am
6:05am
2020-09-30 $ 11.51 (0.88%)
11:02am
6:55am
2020-09-28 $ 11.16 (-2.7%)
6:38am
2020-09-27
8:09am
2020-09-24 $ 9.71 (-0.51%)
4:15pm
2020-09-22 $ 10.45 (6.42%)
10:04am
2020-09-21 $ 9.82 (-2.48%)
1:37pm
9:05am
2020-09-20
6:53am
2020-09-17 $ 7.09 (0.71%)
5:15pm
2020-09-15 $ 7.75 (133.43%)
7:05pm
2020-09-14 $ 7.75 (133.43%)
7:00am
2020-09-12 $ 3.32 (5.73%)
7:00pm
2020-09-03 $ 3.03 (-1.62%)
11:00am
2020-07-14 $ 3.65 (0.27%)
7:44am
2020-07-10 $ 3.06 (-2.08%)
7:01pm
2020-06-16 $ 2.72 (5.84%)
11:00am
2020-06-03 $ 3.42 (67.65%)
11:01am
2020-05-19 $ 2.19 (-4.78%)
3:12pm
8:46am
2020-05-15 $ 2.12 (-73.86%)
11:00am
2020-05-06 $ 7.63 (-2.8%)
11:02am
7:48am
2020-04-24 $ 7.12 (-2.6%)
9:03am
2020-04-23 $ 7.31 (31.95%)
11:02am
2020-03-25 $ 4.15 (-4.82%)
11:00am
2020-03-19 $ 4.23 (11.32%)
11:01am
2020-02-11 $ 7.85 (-0.38%)
11:02am
2020-01-28 $ 8.66 (21.12%)
11:00am
2019-12-31 $ 5.2 (-15.03%)
4:15pm
2019-12-06 $ 1.8 (1.69%)
11:00pm
2019-10-29 $ 1.34 (5.51%)
11:01am
2019-10-24 $ 1.27 (5.83%)
11:01am
2019-09-16 $ 1.27 (4.1%)
11:01am
2019-09-09 $ 1.22 (-12.86%)
7:00am
2019-09-03 $ 1.32 (17.86%)
11:00am
2019-06-18 $ 1.14 (-4.2%)
11:01am
2019-05-28 $ 1.14 (2.7%)
11:00am
2019-04-29 $ 1.12 (-0.88%)
11:00am
2019-04-15 $ 1.17 (1.74%)
11:00am
Total 86
  • 1